UBS Downgrades Nuvalent (NUVL) to Neutral
UBS analyst David Dai downgraded Nuvalent (NASDAQ: NUVL) from Buy to Neutral with a price target of $124.00 (from $138.00).The ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
